Last updated on May 2018

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

Brief description of study

The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis (JIA) with particular in interest in the occurrence of serious infections, autoimmune disorders, and malignancies.

Clinical Study Identifier: NCT01357668

Contact Investigators or Research Sites near you

Start Over

Vyacheslav Chasnyk, Site RU05

Saint-Petersburg State Pediatric Medical Academy
Saint-Petersburg, Russian Federation
  Connect »